Zhao M, Chen Z, Xu T, Fan P, Tian F. Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1221069 (Frontiers Media SA).
Google Scholar
Niznik JD, Ernecoff NC, Thorpe CT, Mitchell SL, Hanson LC. Operationalizing deprescribing as a component of goal-concordant dementia care. J American Geriatr Soc. 2022;71(4):1340 (John Wiley and Sons Inc).
Google Scholar
Daunt R, Curtin D, O’Mahony D. Polypharmacy stewardship: a novel approach to tackle a major public health crisis. Vol. 4, The Lancet Healthy Longevity. Elsevier Ltd; 2023. p. e228–35.
Norton JD, Zeng C, Bayliss EA, Shetterly SM, Williams N, Reeve E, et al. Ethical aspects of physician decision-making for deprescribing among older adults with dementia. JAMA Netw Open. 2023;6(10):e2336728.
Google Scholar
Wang C, Roberts E, Smith G, Carland JE, Cordato NJ. Tools for deprescribing in severe dementia: a scoping review. Int J Geriatr Psychiatry. 2023;38(7):e5959 (John Wiley and Sons Ltd).
Google Scholar
Platen M, Flessa S, Rädke A, Wucherer D, Thyrian JR, Scharf A, et al. Associations between low-value medication in dementia and healthcare costs. Clin Drug Investig. 2022;42(5):427–37.
Google Scholar
Platen M, Fleßa S, Rädke A, Wucherer DI, Thyrian JR, Mohr W, et al. Prevalence of low-value care and its associations with patient-centered outcomes in dementia. J Alzheimer’s Dis. 2021;83(4):1775–87.
Google Scholar
Sawan MJ, Moga DC, Ma MJ, Ng JC, Johnell K, Gnjidic D. The value of deprescribing in older adults with dementia: a narrative review. Expert Rev Clin Pharmacol. 2021;14(11):1367–82.
Google Scholar
Poblador-Plou B, Calderón-Larrañaga A, Marta-Moreno J, Hancco-Saavedra J, Sicras-Mainar A, Soljak M, et al. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry. 2014;14(1):1–8.
Google Scholar
Clague F, Mercer SW, Mclean G, Reynish E, Guthrie B. Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46(1):33–9.
Google Scholar
Cole JA, Gonçalves-Bradley DC, Alqahtani M, Barry HE, Cadogan C, Rankin A, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews. 2023;2023(10). Available from: http://doi.wiley.com/10.1002/14651858.CD008165.pub5.
Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443–52 (Springer Science and Business Media Deutschland GmbH).
Google Scholar
Medication Safety in Polypharmacy. geneva: World health Organization;2019 (WHO/UHC/SDS/2019.11).Licence: CC BY-NC-SA 3.0 IGO. 2019. Available from: http://apps.who.int/bookorders.
Hukins D, Macleod U, Boland JW. Identifying potentially inappropriate prescribing in older people with dementia: a systematic review. Europ J Clin Pharmacol. 2019;75:467–81 (Springer Verlag).
Google Scholar
Rieckert A, Trampisch US, Klaaßen-Mielke R, Drewelow E, Esmail A, Johansson T, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19(1):1–9.
Google Scholar
Renom-Guiteras A, Thürmann PA, Miralles R, Klaaßen-Mielke R, Thiem U, Stephan A, et al. Potentially inappropriate medication among people with dementia in eight European countries. Age Ageing. 2018;47(1):68–74.
Google Scholar
Delgado J, Jones L, Bradley MC, Allan LM, Ballard C, Clare L, et al. Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes. Age Ageing. 2021;50(2):457–64.
Google Scholar
Ponte M, Wachs L, Wachs A, Serra H. Prescribing cascade.A proposed new way to evaluate it. BSAVA Guide to the Use of Veterinary Medicines. Medicina (B Aires); 2017. p. 13–6.
Delgado J, Bowman K, Clare L. Potentially inappropriate prescribing in dementia: A state-of-the-art review since 2007, vol. 10. BMJ Open: BMJ Publishing Group; 2020.
Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis. 2018;61(4):1639–52.
Google Scholar
Espaulella-Panicot J, Molist-Brunet N, Sevilla-Sánchez D, González-Bueno J, Amblàs-Novellas J, Solà-Bonada N, et al. Patient-centred prescription model to improve adequate prescription and therapeutic adherence in patients with multiple disorders. Rev Esp Geriatr Gerontol. 2017;52(5):278–81.
Google Scholar
Molist-Brunet N, Sevilla-Sánchez D, González-Bueno J, Garcia-Sánchez V, Segura-Martín LA, Codina-Jané C, et al. Therapeutic optimization through goal-oriented prescription in nursing homes. Int J Clin Pharm. 2021;43(4):990–7.
Google Scholar
Piers R, Albers G, Gilissen J, De Lepeleire J, Steyaert J, Van Mechelen W, et al. Advance care planning in dementia: recommendations for healthcare professionals. BMC Palliat Care. 2018;17(1):1–7.
Google Scholar
van Poelgeest E, Seppala L, Bahat G, Ilhan B, Mair A, van Marum R, et al. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper. Eur Geriatr Med. 2023.
Model de prescripció centrada en la persona (PCP). Barcelona: Direcció General de Planificació i Recerca en Salut;2022.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Barneto-Soto M, González-Bueno J, Espaulella-Panicot J. Improving individualized prescription in patients with multimorbidity through medication review. BMC Geriatr. 2022;22(1):1–13. https://doi.org/10.1186/s12877-022-03107-2.
Google Scholar
Amblàs-Novellas J, Martori JC, Espaulella J, Oller R, Molist-Brunet N, Inzitari M, et al. Frail-VIG index: A concise frailty evaluation tool for rapid geriatric assessment. BMC Geriatr. 2018;18(1):29.
Google Scholar
Torné A, Puigoriol E, Zabaleta-Del-olmo E, Zamora-Sánchez JJ, Santaeugènia S, Amblàs-Novellas J. Reliability, validity and feasibility of the frail-vig index. Int J Environ Res Public Health. 2021;18(10):5187.
Google Scholar
Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199–208.
Google Scholar
Saezdelafuente J, Such Diaz A, Cañamares-Orbis I, Ramila E, Izquierdo-Garcia E, Esteban C, et al. Cross-cultural adaptation and validation of the medication regimen complexity index adapted to Spanish. Ann Pharmacother. 2016;50(11):918–25.
Google Scholar
Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham ; B Gwen, et al. A Drug Burden Index to Define the Functional Burden of Medications in Older People. Available from: http://archinte.jamanetwork.com/.
Molist Brunet N, Sevilla-Sánchez D, Amblàs Novellas J, Codina Jané C, Gómez-Batiste X, McIntosh J, et al. Optimizing drug therapy in patients with advanced dementia: A patient-centered approach. Eur Geriatr Med. 2014;5(1):66–71. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1878764913009261.
Molist Brunet N, EspaulellaPanicot J, Sevilla-Sánchez D, Amblàs Novellas J, CodinaJané C, AltimirasRoset J, et al. A patient-centered prescription model assessing the appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med. 2015;6(6):565–9.
Google Scholar
González-Bueno J, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Molist-Brunet N, Codina-Jané C, Espaulella-Panicot J. Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity. Eur J Clin Pharmacol. 2022;78(1):127–37.
Google Scholar
Sawyer RJ. The growing challenge of dementia care. NEJM Catal. 2021;2(9):22.
Nguyen AD, Baysari MT, Duong M, Zheng WY, Ng B, Lo S, et al. Communicating deprescribing decisions made in hospital with general practitioners in the community. Intern Med J. 2021;51(9):1473–8.
Google Scholar
Tent S, Verhoeff M, Festen S, van Munster BC. Goals of older hospitalized patients with multimorbidity. Eur Geriatr Med. 2023;14(2):229–37.
Google Scholar
Sawan MJ, Moga DC, Ma MJ, Ng JC, Johnell K, Gnjidic D. The value of deprescribing in older adults with dementia: a narrative review. Expert Rev Clin Pharmacol. 2021;4(11):1367–82.
Google Scholar
Sawan MJ, Jeon YH, Bond C, Hilmer SN, Chen TF, Wennekers D, et al. Caregivers’ experiences of medication management advice for people living with dementia at discharge. J Eval Clin Pract. 2021;27(6):1252–61.
Google Scholar
Granger C, Albrecht G, Hamilton BB. Outcome of comprehensive medical rehabilitation: measurement by PULSES profile and the Barhtel Index. Arch Phys Med Rehabil. 1979;60:145–54.
Google Scholar
Brusselaers N, Lagergren J. The charlson comorbidity index in registry-based research: Which version to use? Methods Inf Med. 2017;56(5):401–6.
Google Scholar
Reisberg B, Ferris S, De Leon M. The Global Deteriorations Scale for assessment of primary degenerative dementia. Am J Psychiatri. 1982;39:1136–9.
Maust DT, Kim HM, Strominger J, Chang C, Langa KM, Bynum J, et al. Central nervous system‐active polypharmacy among community‐dwelling persons with dementia in the United States. Alzheimer’s & Dementia. 2020 Dec;16(S10).
Amblàs-Novellas J, Espaulella J, Rexach L, Fontecha B, Inzitari M, Blay C, et al. Frailty, severity, progression and shared decision-making: A pragmatic framework for the challenge of clinical complexity at the end of life. Eur Geriatr Med. 2015;6(2):189–94.
Google Scholar
Reuben DB, Jennings LA. Putting goal-oriented patient care into practice. J American Geriatr Soc. 2019;64:1342–4.
Google Scholar
Gómez-Batiste X, Turrillas P, Tebé C, Calsina-Berna A, Amblàs-Novellas J. NECPAL tool prognostication in advanced chronic illness: a rapid review and expert consensus. BMJ Support Palliat Care. 2020;12:1–11.
link